Company Description
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.
It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases.
The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.
It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.
The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
| Country | United States |
| IPO Date | Apr 4, 1994 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 82 |
| CEO | David I. Portnoy |
Contact Details
Address: 700 Brooker Creek Boulevard Oldsmar, Florida United States | |
| Website | https://www.cryo-cell.com |
Stock Details
| Ticker Symbol | CCEL |
| Exchange | NASDAQ |
| Fiscal Year | December - November |
| Reporting Currency | USD |
| CIK Code | 0000862692 |
| CUSIP Number | 228895108 |
| ISIN Number | US2288951088 |
| Employer ID | 22-3023093 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| David I. Portnoy | Chairman & Co-Chief Executive Officer |
| Mark L. Portnoy | Co-Chief Executive Officer & Director |
| Jill M. Taymans | Chief Financial Officer & Vice President of Finance |
| Oleg Mikulinsky | Chief Information Officer |
| Dr. Joanne Kurtzberg M.D. | Medical Director and Member of Medical & Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 4 | Filing |
| Nov 12, 2024 | S-8 | Filing |
| Oct 31, 2024 | 4 | Filing |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 17, 2024 | 10-Q/A | [Amend] Quarterly Report |
| Oct 17, 2024 | 8-K | Current Report |
| Oct 15, 2024 | 10-Q | Quarterly Report |
| Oct 07, 2024 | ARS | Filing |
| Oct 07, 2024 | DEF 14A | Filing |